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Abstract 
Objective: Recently controversy has surrounded the dimensionality of the Hospital Anxiety 
and Depression Scale (HADS). We assessed the dimensionality of the HADS in a large 
international sample of patients with ischaemic heart disease (IHD) using confirmatory 
factor analysis (CFA). The analysis of an international sample enabled the current study to 
broaden knowledge gained from existing studies with small, regional samples.  
Methods: Data from the HeartQoL study of patients with IHD (n=6,241, 22 countries 
speaking 15 languages) were analysed using CFA. 
Results:  CFA indicated a hierarchical bifactor solution, with mostly strong item loadings on 
a general factor (explaining 73% of the variance), and weak to very weak loadings on 
orthogonal depression (16%) and anxiety (11%) subscales. The bifactor model fit the data 
significantly better than both the original bidimensional model and Dunbar’s higher-order 
three-factor model.   
Conclusion: These results, from a large international sample of patients with IHD, suggest 
that the HADS scale is dominated by a single general distress factor. Although the best CFA 
model fit was a hierarchical bifactor solution, the subscales had weak item loadings, 
providing little psychometric evidence of the ability of the HADS to differentiate anxiety and 
depressive symptoms. It is argued that clinicians and researchers working with patients with 
IHD should abandon the HADS and use alternative measures of depression and anxiety. 
 
Keywords: Dimensionality, Hospital Anxiety and Depression Scale, Ischaemic Heart Disease, 
Confirmatory factor analysis  
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INTRODUCTION 
Studies involving post-myocardial infarction patients have shown that 20% have major 
depression (1), while Frasure-Smith et al. have established a prevalence of 5.3% for 
Generalised Anxiety Disorder (GAD) in patients with stable coronary artery disease (2). The 
relevance of the presence of anxiety and depression in cardiac patients has repeatedly been 
shown in systematic reviews; both are associated with higher death rates and poorer 
prognoses in general in cardiovascular disease (3-5). 
Zigmond and Snaith originally developed the Hospital Anxiety and Depression Scale (HADS) 
in order to assess anxiety and depression in a medical setting without potential confounding 
from physical symptoms (6). It has since been used prolifically in clinical and research 
settings (7). More recently, however, the HADS has been shown to have poor content 
validity. The exclusion of somatic items, use of colloquial British expressions (such as 
“‘butterflies’ in the stomach”), and emphasis on anhedonia mean that the assessed 
symptoms do not accurately reflect the diagnostic criteria for major depressive disorder or 
GAD (8-10). Doyle et al. found that only 4 of 13 diagnostic symptoms for major depression 
were assessed by the depression subscale (9). Maters et al. further demonstrated that the 
colloquial British expressions used mean that translation of the HADS is problematic, and 
that several different versions of the HADS can exist in one language leading to 
interpretation issues (10). 
Previous reviews of the literature support the psychometric validity of the HADS as a 
bidimensional questionnaire for assessing separate factors of anxiety and depression (7, 11), 
and a recent meta-analysis demonstrated adequate case-finding ability for the depression 
and anxiety subscales (12). However, controversy has arisen regarding the scale’s purported 
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bidimensional structure and the ability of the HADS to distinguish anxiety and depression in 
both cardiac and other populations.   
Cosco et al. recently reviewed analyses of the structure of the HADS and found that only 
half of the included studies reported two-factor structures (13).  Even among these, the 
majority featured anomalous factor loadings, for example, depression items loading on the 
anxiety factor. The authors found heterogeneous factor structures within and across a 
variety of sample populations including cardiac, cancer and non-clinical. They concluded 
that the evidence to support the originally proposed bidimensional anxiety-depression 
structure is insufficient (13). As a result, Coyne and van Sonderen called for the 
abandonment of the HADS as a scale for measuring anxiety and depression (14).   
However, Norton et al. suggested that the presence of an overarching general distress 
factor may explain the inconsistent results regarding the latent structure of the HADS, and 
pointed to two alternative hierarchical models (higher-order and bifactor) which are said to 
represent hierarchical dimensionality structures (15). The higher-order model, proposed by 
Dunbar et al. (16), is based on the Tripartite theory of anxiety and depression (17) and is 
currently the most-widely supported three factor structure (13). Tripartite theory posits 
anxiety and depression as lower-level constructs in a tripartite structure (18), with a higher-
order general distress factor termed Negative Affectivity (NA) (17). Norton et al. also 
suggested bifactor models involving a general factor, such as distress, upon which all items 
load, and more specific group factors upon which related items load. In contrast to higher-
order models, the general factor is at the same level as the group factors, and as a result the 
variance explained by the general factor can be separated from the other factors (19).   
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Norton et al.  went on to explore 10 alternative models for the HADS, including Dunbar's 
higher-order model (16) and two bifactor models, using meta-confirmatory factor 
analysis. This demonstrated that a bifactor structure (one general factor and two group 
factors) consisting mostly of a general distress factor, which accounted for over 70% of the 
variance, provided the best solution (19). This was true across community and 
cardiovascular disease samples and various language groups. The bifactor model provided a 
more optimal solution than any previously considered structure (19). Norton et al. 
concluded that these results indicate that the HADS taps into autonomic arousal and 
anhedonia as originally intended but is saturated by the presence of strong general factor 
(19).  
Anxiety and depression are frequently comorbid conditions (20, 21), and share symptoms 
(22), making them difficult to distinguish. It may be that the strong general factor found by 
Norton et al. (19) is a product of the strongly connected symptoms of anxiety and 
depression in accordance with the network model of psychiatric symptoms (23).  
Although Norton et al. used multiple samples and papers from different countries, their 
study largely used a meta-analysis approach relying on summary statistics (19). Notably, 
61% of published studies from the Cosco et al. review (13) were omitted due to inability to 
obtain summary data, and this may have biased the findings.  
The aim of this paper is to assess the dimensionality of the HADS in a large, international 
sample of patients with ischaemic heart disease (IHD) by employing CFA to test the validity 
of the originally proposed bidimensional structure as well as two hierarchical models: 
Dunbar’s higher-order model (16) and the bifactor model (19).  
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METHODS 
Participants 
Participants for this analysis were drawn from the HeartQoL Project (24) The objective of 
the HeartQoL Project was the development of a new health-related quality of life scale 
specific to IHD (24). Patients with IHD (either angina, myocardial infarction or ischaemic 
heart failure) across 5 regions (Eastern, Southern, and Western European regions, 
Scandinavia and an English-speaking region including the UK, Ireland, Australia, Canada and 
the USA) were enrolled in the HeartQoL Project between 2002 and 2010. In the cross-
sectional survey phase, data on various patient reported outcome measures (including the 
HADS) were collected across 54 sites in 22 countries where 15 languages (Norwegian; 
Swedish; Danish; Dutch; French; Flemish; German; Italian; Portuguese; Spanish; Polish; 
Russian; Ukrainian; Hungarian; and English) are spoken (24).  
For the confirmatory factor analysis (CFA) 6,109 of the 6,241 participants were retained 
following the use of pooled correlation matrices.   
Materials 
The HADS is a 14-item self-report measure with a four-point scale (6). The scale is 
comprised of two seven-item subscales designed to assess anxiety and depression (HADS-
A; HADS-D), and uses a mixture of negative and positive items and varying response 
options.  Even-numbered items are designed to measure depression while odd-numbered 
items are said to measure anxiety. Sample items include "I feel tense or wound up" (HADS-
A), with response options ranging from "Not at all" to "Most of the time"; and "I look 
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forward with enjoyment to things" (HADS-D), with responses ranging from "As much as I 
ever did" to "Hardly at all". 
Where HeartQoL investigators had access to a HADS translation in their own language, this 
was used (although it is unclear what version was used if several were available) (10). If no 
appropriate translation was available, investigators used the Outcomes Trust backwards 
and forwards approach to translations and the HADS was translated into that language from 
the English version. All participants were given the measure in their language of preference 
(24). Cronbach’s alphas for both the overall scale (α = .87) and anxiety and depression 
subscales (α = .81, α = .79) were high indicating good internal consistency. 
Analysis of scores in the clinical setting suggest that a score of 0 to 7 for either subscale 
could be considered as being in the normal range while scores above this suggest possible 
or probable ‘caseness’ (25).  
 
Statistical Analysis 
All statistical analyses were carried out using AMOS version 21.0.  
Confirmatory factor analysis (CFA) 
CFA was employed to confirm the best model of fit. All HADS items were correlated and the 
resulting pooled matrix was analysed. The three models below were tested (see Figure 1): 
 Zigmond and Snaith’s originally proposed bidimensional structure (21)  
 Dunbar et al.’s (16) higher-order model.  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
8 
 
 The hierarchical bifactor structure which emerged from Norton et al.’s recent meta 
CFA (19)  
 
The maximum likelihood method was used to examine the covariance matrices of the items. 
Several indices were used to assess the model fit of the three models tested. The statistics 
usually reported in CFA are χ2 (with degrees of freedom and p-value), goodness-of-fit index 
(GFI), comparative fit index (CFI) and root mean square error of approximation (RMSEA) 
(26). The χ2 statistic is an overall test of how well the hypothesized model fits the data and a 
significant χ2 indicates a model that does not fit the data well. Because the χ2 statistic 
assumes multivariate normality and is affected by large sample size (i.e. a model with 
relatively good fit for a large dataset can still be rejected), additional indices of fit (i.e. TLI, 
GFI, CFI, SRMR and RMSEA) must be used to make a judgement regarding the fit of the 
model. The Tucker-Lewis index (TLI) is a relative fit index. It is relatively unaffected by 
sample size (27) and values over .90 or .95 are considered acceptable (28). The GFI and CFI 
should have values over 0.95 and the RMSEA value should be below .05 (26). Akaike's 
information criterion (AIC) is a modification of the standard goodness-of-fit χ2 statistic that 
includes a penalty for complexity. This index is useful for making comparisons among two or 
more models, with lower values indicating better fit. The Bayesisan information criterion 
(BIC) is closely related to AIC and also penalizes model complexity based on the number of 
parameters. Again lower values are preferred.  The SRMR (Standardized Root Mean 
Residual) is a descriptive fit index, a cutoff value close to .08 is recommended and lower 
values indicate better fit (28).  
 
Relative fit of the models was assessed by examining change in chi-square values across 
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the models (Δ χ2). However, this test is sensitive to sample size, and is likely to reach the 
threshold for significance in large samples. Accordingly, Cheung and Rensvold (29) have 
argued that changes in alternative fit indices should be assessed to compare relative fit of 
nested models, as these indices are not as sensitive to sample size. Differences in CFI 
across the three models were therefore assessed, according to a threshold of 0.01 
suggested by Cheung & Rensvold (29).  
 
RESULTS 
Sample description 
Demographics for the total sample are shown in Table 1. The overall sample was composed 
of 75.1% (4,690) men and 27.7% (1,541) women, typical of the male dominated gender 
distributions in heart disease populations. The majority of respondents were married with 
an average age of 62.3 (Median = 62). Regarding regions, 15.9% of the sample was derived 
from Scandinavia, 23.1% from Western Europe, 18.1% from Southern Europe, 20.9% from 
Eastern Europe and finally 22.0% from the English-speaking region.  There were no 
significant differences between HADS respondents and non-respondents (n=143) in terms of 
both clinical and sociodemographic data (data not shown). Based on HADS scores, 34.6% of 
the sample were anxious while 25.1% were depressed (24)  (i.e. had a HADS score greater 
than 7).   
The correlation between the anxiety and depression subscales was 0.625.      
 
Confirmatory factor analysis 
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CFA of the pooled correlation matrix across all samples is shown in Table 2. The bifactor 
model with two group-factors and a general factor (model 3) provided the best fit. While 
the other models also fit the data, the bifactor model provided a significantly better fit 
based on the χ2 test for differences and performed best with regard to LI, AIC, BIC, SRMR, 
GFI, CFI and RMSEA. Table 2 shows the CFA results. The bifactor model (.45) was the only 
solution for which RMSEA was <.05, indicating a good fit. Both Dunbar et al.’s (.052) and 
Zigmond and Snaith’s (.058) models exceeded the .05 criterion.  AIC and BIC penalize model 
complexity and according to these measures Dunbar’s model fit better than Zigmond and 
Snaith’s while the bifactor provided superior fit to both. Considering TLI, the bifactor model 
(.96) was the only solution to meet the .95 criterion (Hu and Bentler 1999). The Δ CFI was 
>0.01, indicating that the change in fit between models was meaningful. Anxiety and 
Depression factor correlations and factor loading ranges for all three models are presented 
in Table 3.  
The bifactor model consists of a global factor (explaining 73% of the variance) with two 
separate orthogonal factors representing anxiety (11%) and depression (16%) subscales. 
The anxiety subscale had rather poor loadings while the depression items clustered 
somewhat more strongly (Table 4). The general factor displayed the highest loadings. All 14 
general factor loadings were statistically significant. Two depression factor loadings (items 8 
and 14) and four anxiety factor loadings (items 1, 5, 9 and 11) were not statistically 
significant (30).  
The inter-factor correlation for this model was .08 (see model 3 in Figure 1). It is important 
to point out that the model would not have fit without this correlation.  
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Discussion  
As highlighted in recent reviews, many studies involving a variety of populations have 
revealed factor structures contrary to the two intended HADS subscales (13, 19). This study 
is the first to assess the dimensionality of the HADS in a large international sample of 
patients with IHD. While this commonly used scale is thought to differentiate between 
anxiety and depression, the results of the present analysis and other recent studies (19, 31-
36) provide little psychometric evidence in support of its factorial validity in this regard. 
The bifactor model fit the data better than the original bidimensional structure or Dunbar’s 
model (16), thus supporting the findings of Norton et al. (19). The ΔCFI indicated that the 
difference in model fit was meaningful. Norton et al.’s bifactor model did not specify an 
inter-factor correlation, whereas a bifactor model did not fit our data without specifying this 
inter-factor correlation. However, this very slight correlation (.08), which may merely 
represent an anomaly from our own data, was deemed inconsequential in terms of overall 
results and conclusions. Overall, and supporting the findings of Norton et al.(19), it seems 
that while two subscales exist in the HADS items, the scale is dominated by a general 
distress factor in patients with IHD and thus may not be sensitive to disorder-specific 
symptoms in this patient population. 
The bifactor solution helps to explain the conflicting findings of previous studies employing 
different analytic methods (19). Prior to Norton et al., reviews of CFA studies of the HADS 
generally pointed to a three factor structure with either a higher-order negative affectivity 
factor or the anxiety subscale split into two highly correlated factors (7, 13, 19, 37). Norton 
et al. have suggested these findings may simply represent overextraction following failure to 
account for a general factor (19). Exploratory factor analyses (EFA) of the HADS have 
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typically produced two factor solutions and as Norton et al. have reasoned this is likely due 
to rotation motivated by the aim to find a simple structure. The initial unrotated factor 
found in EFA studies indicates a general factor and it is only when this is rotated that the 
anxiety-depression factorizarion emerges (19).  Straat et al. have also noted the tendency 
for EFA to detect heterogeneity in the inter-item correlation matrix, suggesting 
multidimensionality even when the factor structure is actually weak (36).  Finally, the fact 
that IRT studies of the HADS consistently produce unidimensional solutions (13) also accords 
with the presence of a strong dominant factor (19). Thus all the solutions produced by 
previous studies of the latent structure of the HADS are understandable in the presence of a 
strong general factor (19). Unlike these past analyses, the current study, in line with Norton 
et al.’s meta CFA, allowed for the presence of a general factor by testing two hierarchical 
models.  
Support for the bifactor structure, and the associated claim that the HADS measures general 
distress or what is common between anxiety and depression, is also found in sensitivity and 
specificity studies. For instance, the general distress factor which saturates the scale seems 
to be equally good at identifying depression and anxiety (38, 39).  Also, evidence suggests 
the anxiety subscale may be as effective as the depression subscale in screening for 
depressive disorder (40).  
As noted above, the HADS has poor content validity and is often inadequately translated (9, 
10). However, even if the HADS were to fully cover the symptoms of these two disorders 
and avoid colloquial British, most efforts to differentiate anxiety and depression in a single 
self-report questionnaire will fail. It must be remembered that anxiety and depression are 
frequently comorbid conditions (20, 21) which also feature shared symptoms (22). The 
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results of the current study suggest that the anxiety and depression factors, as measured 
by the HADS are best explained by a general factor, perhaps due to the issues around 
content validity mentioned earlier (i.e. not assessing enough symptoms which are unique 
to anxiety and depression).  
It has recently been suggested that the endemic comorbidity seen in psychopathology 
research may actually be a result of the misconceptualization of mental disorder. In line 
with this view, Cramer et al. have developed a network approach to mental disorders and 
comorbidity where symptoms are viewed not as indicators of latent conditions but as 
components in a network (41). Employing this network model Borsboom et al. showed that 
half of the symptoms in the DSM-IV are connected and hypothesized that a significant part 
of DSM-IV comorbidity is therefore the result of direct relations between symptoms of 
multiple disorders. Consequently, they suspect that higher-order factors may be similar in 
form to regions of strongly connected symptoms (42). This network approach to mental 
disorders, and explanation of comorbidity as a result of the effects of symptoms shared by 
multiple disorders (41), is consistent with the model of the HADs identified here, with 
shared variance between symptoms of anxiety and depression saturated by a general 
distress factor. Borsboom et al. have commented on the comorbidity between major 
depressive episode and GAD in particular and illustrate a causal chain of directly related 
symptoms (42). Most importantly, this network model of psychiatric symptoms has been 
shown to fit in with population statistics on prevalence and comorbidity while also 
accommodating the idiosyncratic unpredictability of the individual person (42).  
After highlighting the difficulty in distinguishing distinct anxiety and depression factors for 
the HADS scale, Norton et al. concluded that it would be best computed as a global score 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
14 
 
suggesting that this 14-item scale may be an effective clinical tool for identifying unspecified 
cases of distress (19). This is a solution which was previously put forward by Cosco et al. 
who uncovered a unidimensional HADS model in a cardiac population in Ireland using IRT 
methods (43). Naming the factor ‘General Psychological Distress’, they interpreted this 
single overarching dimension as a clinically useful measure of general psychological distress, 
citing the symptomatic overlap demonstrated by the HADS as strong evidence for their 12-
item unidimensional psychological distress scale which was interpreted as capturing 
symptoms of both anxiety and depression. In the current study, all 14 items loaded onto the 
general factor and yet this model may well be closely related to Cosco et al.’s 12-item 
solution (43) considering both involved strong general factors revealed in cardiac 
populations.  
Given its wide usage and familiarity in clinic settings retaining the use of the HADS is an 
attractive option. Although evidence consistently suggests that the HADS does not fulfil 
the role it was originally intended to – measure depression and anxiety as distinct factors 
– we argue here that it may be possible to meaningfully use the HADS as a global score. 
However some caution is required. The HADS as a global score has not yet been fully 
tested for psychometric and clinical validity. If adequately validated a global score may 
also prove useful in interpreting already collected data. Where new research is being 
conducted however, we urge researchers and clinicians to avoid the HADS and use 
alternative measures of anxiety and depression with IHD patients. 
It has previously been suggested that clinicians and researchers wishing to assess anxiety 
and depression should abandon the HADS and instead rely upon other established 
instruments (8) (possibilities include the Patient Health Questionnaire (PHQ-9;(44)), the 
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Generalised Anxiety Disorder Scale (GAD-7;(45)) and the Inventory of Depression and 
Anxiety Symptoms (IDAS;((46)) (19)) and this paper provides further support for this 
recommendation in one international population - IHD patients.   
This study is somewhat limited by the lack of information on specific language versions 
used. For instance, there are four available Dutch translations of the HADS (10). 
Furthermore, the way in which outcomes were pooled means it is possible that unexplored 
measurement characteristics across cultural groups or linguistic versions of the HADS may 
have influenced results. Finally, depression and anxiety were not clinically assessed, and this 
is a weakness as we could not assess the clinical validity, especially the sensitivity and 
specificity of the instrument. The HADS data in this study was treated as continuous as has 
frequently been the case throughout the HADS literature as well as in recent studies (47). 
On reflection however, we have concluded that it may be better to treat the data as quasi-
continuous and we recommend future investigations address this. The study was 
strengthened by its large international sample.  
Conclusions  
CFA led to the conclusion that the underlying measurement model of the HADS structure 
in this large international sample of patients with IHD can be best described as a 
hierarchical bifactor model. It seems that the HADS does not psychometrically distinguish 
well between anxiety and depression in this group. While the HADS computed as a global 
score may be an effective clinical tool for identifying unspecified cases of distress, at this 
stage we lack sufficient information about its validity in this role to advocate for its 
widespread use. The bifactor model provides a good fit but a largely impractical solution 
where clinicians and researchers are concerned. As such clinicians and researchers working 
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with patients with IHD should avoid the HADS and instead employ alternative measures of 
depression and anxiety.  
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Figure 1. Factor loading patterns for each model 
 
 
 
 
 
Model 1 (Zigmond & Snaith) Model 2 (Dunbar, higher-order) Model 3 (Norton, bifactor) 
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Table 1. Demographic information for total sample (N = 6,241)  
  
Mean  
Age 
(SD) 
         62.34                                   
          (11.27) 
  
%  
Primary diagnosis  
Angina  33.2 
Myocardial Infarction  37.2 
Heart Failure  29.6 
  
Men 75.1 
  
Marital Status  
Single  11.7 
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Married  74.2 
Other 12.6 
Education 
High school not completed  
High school completed  
More than high school 
Occupation 
Blue collar  
White collar  
Managerial responsibilities 
 
36.7 
30.7 
28.4 
 
37 
40.8 
37 
Pleased with financial situation 54.7 
Note. Some percentages do not add up to 100% due to missing data.  
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Table 2. Results of Confirmatory factor analysis of the HADS in patients with IHD (n=6,109)  
 Model χ2 DF χ2 
difference 
(DF) 
RMSEA TLI CFI Δ CFI GFI AIC BIC SRMR 
1 Zigmond & Snaith Original 
bidimensional model[6] 
1636.91 76 - .058 .929 .940 - .962 1694.91 1889.71 .027 
2 Dunbar et al. Higher- order model 
[25] 
1308.59 75 328.33  
(1) 
.052 .943 .953 .013 .971 1386.59 1570.10 .024 
3 Norton et al. Bifactor model [19] 820.98 62 487.60 
(13) 
.045 .958 .971 .018 .981 906.98 1192.60 .018 
Note. DF = degrees of freedom; RMSEA = root mean squared error of approximation; TLI = Tucker-Lewis index; CFI = comparative fit index; Δ CFI = change in comparative fit 
index; GFI = goodness of fit index; AIC = Akaike information criterion; BIC = Bayesian information criterion; SRMR = standardized root mean residual. 
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Table 3. Factor Loading Ranges and Correlations 
 Model Anxiety  Depression  
 
General/Higher-order  
 
Correlation 
  Lowest Highest Lowest Highest Lowest Highest  
1 Zigmond & Snaith Original 
bidimensional model[6] 
 
.00 .73 .00 .70 N/A .78 
2 Dunbar et al. Higher- order model [25] 
 
.00 .75 .00 .70 .39 .74 N/A 
3 Norton et al. Bifactor model [19] -.31 .30 .00 .54 .38 .71 .08 
Note. Correlation = correlation between anxiety and depression factors. N/A = not applicable in case of this model.  
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Table 4. Bifactor model loadings for the sample of 6,109 IHD patients 
  
 
General 
factor 
Depression Anxiety 
1 A I feel tense or wound up .69 .00 .00 
2 D I still enjoy things I used to enjoy .46 .48 .00 
3 A I get a sort of frightened feeling as if something awful is about to happen      .66       .00    -.37 
4 D I can laugh and see the funny side of things .56 .40 .00 
5 A Worrying thoughts go through my mind .71 .00 -.14 
6 D I feel cheerful .61 .31 .00 
7 A I can sit at ease and feel relaxed .70 .00 .30 
8 D I feel as if I am slowed down .42 .25 .00 
9 A I get a sort of frightened feeling like “butterflies” in the stomach .48 .00 -.24 
10 D I have lost interest in my appearance .38 .30 .00 
11 A I feel restless as if I have to be on the move .43 .00 .05 
12 D I look forward with enjoyment to things .49 .54 .00 
13 A I get sudden feelings of panic .64 .00 -.31 
14 D I can enjoy a good book or radio or TV program .42 .25 .00 
Anxiety subscale: Skewness = .62, Kurtosis = -.01; Depression subscale: Skewness = .81, Kurtosis = .02. 
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Highlights 
 
 We used CFA to test 3 models of the Hospital Anxiety and Depression Scale using data from the HeartQoL 
study.  
 The bifactor model provided the best fit.  
 The HADS scale seems to be best explained by a general distress factor in patients with Ischaemic Heart 
Disease 
